Doug
Doug has enrolled in the UC Berkeley – UCSF Joint Medical Program (JMP), where he will earn an MS in Health and Medical Sciences from UC Berkeley in 2026 and an MD from UC San Francisco in 2029. He also holds a BA in Neurobiology from the College of Wooster.
Annelise
Annelise holds an MD from Columbia and a BA in Biology from Harvard. She is now an intern in her transitional year at Beth Israel Brockton Hospital, after which she will train at the University of California San Francisco for her dermatology residency.
Sadia
Sadia holds a BA in Social Anthropology from Harvard University. After graduating, she spent two years working in global health advocacy and policy work. Currently, she is pursuing an MD-PhD at UCSF.
Patricia W.
Patricia holds a BA in French and Anthropology from Hunter College and a PhD in French Literature from CUNY Graduate Center. She has taught French at Fordham University, Hunter College, and The New School.
Rodrigo
Rodrigo is a 4th year medical student at the University of California, San Francisco. Originally from Los Angeles, he studied nutritional science at Cornell University, where he graduated with honors and distinction.
Claire H.
Claire holds a BA in Molecular and Cellular Biology from Bowdoin College. After working in a pediatric oncology research lab at Dana-Farber Cancer Institute/Harvard Medical School, she is now pursuing a PhD in Biomedical Science at the University of California San Francisco.
Zaina
Zaina earned her BS in Biological Engineering at the Massachusetts Institute of Technology (MIT). She is currently pursuing an MD/PhD at UC San Francisco and UC Berkeley.
Jahnavi
Jahnavi is an MD Candidate at the University of California, San Francisco School of Medicine and an MPH Candidate at the UC Berkeley School of Public Health. Previously, she earned her BA in Neurobiology and Global Health and Health Policy at Harvard College.
Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Pedro G.
Pedro is a 2nd-year medical student at UCSF. As a native Spanish speaker, he started studying Mandarin in middle school for his foreign language requirement. Following this passion, he graduated from Stanford University with a BA in East Asian Studies, focusing on the Chinese healthcare system.